AI powers digital twins of cells/molecules, speeding early drug discovery and cutting trial-and-error work. Read more here.

Join Bisnow’s Chicago Quantum & Life Science Forum - the only event bringing together researchers, entrepreneurs, investors ...

Biotechnology today demands not just domain knowledge but also creativity, ethics, and transdisciplinary thinking, as ...

Angelini’s investments will be made through its Angelini Ventures arm. EIB and Angelini plan to support between seven and 10 ...

Bertrand Foucher, CEO of ONLYLYON, is positioning Lyon as Europe’s rising hub for industry, innovation, and global talent.

But sometimes, this top investor who focuses on innovation does see eye-to-eye with analysts, and the perfect example of this ...

The Republic may not have a major player to call its own, but licensing deals and early-stage breakthroughs can still count ...

Home to over 2,000 companies from more than 90 countries, Masdar City Free Zone is a recognized business hub in Abu Dhabi, ...

The Maharashtra government will set up a Life Sciences Innovation and Incubation Centre to boost research and development in the pharmaceutical and biotech sectors, Food and Drugs Administration (FDA) ...

Artificial intelligence (AI) is not only transforming new drug development and clinical trials but also changing the form of ...

Martin Babler, CEO of South San Francisco drug-development company Alumis, said skittishness among investors concerned about ...

A Bold Step Reflecting Customer Obsession, Strategic Growth, and a New Era for InstemBOSTON--(BUSINESS WIRE)--Instem, a global leader in SaaS solutions for life sciences R&D, today announced the ...